Because NGF is detectable in physiologically effective amounts in the blood and NTRK1 receptors are expressed in the spiral ganglion, therapeutic trials have been undertaken for sensorineural hearing loss and tinnitus (Zhou et al. 2009; Salvinelli et al. 2015). Here, NGF is linked to sensorineural hearing loss disorder.